# Reveal LINQ™ In-Office 2 (RIO2) Study International

> **NCT02412488** · NA · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 191 (actual)

## Conditions studied

- Arrhythmia

## Interventions

- **OTHER:** Out of cathlab insertion

## Key facts

- **NCT ID:** NCT02412488
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-09-22
- **Final completion:** 2016-10-20
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2019-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412488, "Reveal LINQ™ In-Office 2 (RIO2) Study International". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02412488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*